Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction.
Heart repair by stem cell treatment may involve life-threatening arrhythmias. Cardiac progenitor cells (CPCs) appear best suited for reconstituting lost myocardium without posing arrhythmic risks, being commissioned towards cardiac phenotype. In this study we tested the hypothesis that mobilization...
Guardado en:
Autores principales: | Leonardo Bocchi, Monia Savi, Gallia Graiani, Stefano Rossi, Aldo Agnetti, Francesca Stillitano, Costanza Lagrasta, Silvana Baruffi, Roberta Berni, Caterina Frati, Mario Vassalle, Umberto Squarcia, Elisabetta Cerbai, Emilio Macchi, Donatella Stilli, Federico Quaini, Ezio Musso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25718372cf8949d1aae3b1a499700e19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats.
por: Francesca Delucchi, et al.
Publicado: (2012) -
Monomorphic Ventricular Arrhythmias in Athletes
por: Jeffrey J Hsu, et al.
Publicado: (2019) -
Approach to inherited arrhythmias in pregnancy
por: Lisa Albertini, et al.
Publicado: (2021) -
Flight safety in patients with arrhythmia
por: Fahrettin Katkat
Publicado: (2021) -
Coronavirus Disease 2019 and Cardiac Arrhythmias
por: Antoni Martínez-Rubio, et al.
Publicado: (2020)